About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Pancreatic and Lung Cancer May Soon Find Their Match in Synthetic Compounds

by Tanya Thomas on March 13, 2011 at 7:39 AM
Font : A-A+

 Pancreatic and Lung Cancer May Soon Find Their Match in Synthetic Compounds

Scientists have uncovered a chemical compound that may eventually lead to a drug that fights cancers that are dependent on a particular anti-viral enzyme for growth.

Researchers at UT Southwestern Medical Center are testing the compound's effectiveness at fighting tumors in mice. If it is successful, they will then work to develop a drug based on the compound to combat pancreatic and non-small cell lung cancer, two cancer types in which this particular enzyme, TBK-1, often is required for cancer cell survival.

Advertisement

"Our prediction is that TBK-1 is a good pharmacological intervention target for a subset of lung and pancreas cancers that are addicted to the activity of this enzyme. We believe there is a large population of cancer patients that could respond to inhibition of this activity," said Dr. Michael White, professor of cell biology and senior author of the study in the Feb. 18 issue of Molecular Cell.

The investigation, which lasted three and a half years, revealed how activation of the natural virus-fighting protein TBK-1 is hijacked in cancer cells to support growth and survival.
Advertisement

More than 250,000 compounds were screened to find one that would inhibit the enzyme's cancer-protection mechanism. The most effective, a compound called 6-aminopyrazolopyrimidine developed in collaboration with pharmaceutical company Amgen, blocked TBK-1's effects in 40 percent to 50 percent of the non-small cell lung cancer and pancreatic cancer tissue cultures tested, reducing cancer growth.

"We found a biological activity that some cancer cells need to be able to survive, and we found a way to turn it off," said Dr. White.

"We've illuminated the dark matter of regulation of an incredibly important oncogenic survival pathway," he said.

Source: ANI
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Alarming Cesarean Section Trends in India - Convenience or Compulsion of Corporate Healthcare
Quiz on Low-Calorie Diet for Diabetes
World Heart Day in 2022- Use Heart for Every Heart
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Pancreatic Cancer Lung Biopsy Lung Cancer Cancer and Homeopathy Cancer Facts Asbestosis Cancer Tattoos A Body Art Pancreatitis Pneumoconiosis 

Most Popular on Medindia

Blood Donation - Recipients Turmeric Powder - Health Benefits, Uses & Side Effects Find a Doctor Noscaphene (Noscapine) Loram (2 mg) (Lorazepam) Sinopril (2mg) (Lacidipine) Indian Medical Journals Daily Calorie Requirements Blood Pressure Calculator Post-Nasal Drip
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Pancreatic and Lung Cancer May Soon Find Their Match in Synthetic Compounds Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests